Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
Udo S. Gaipl +3 more
doaj +1 more source
Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models. [PDF]
Hoang TT +14 more
europepmc +1 more source
Radiotherapy and immunotherapy for advanced cancers: A meta-analysis of dose, sequencing, and survival patterns. [PDF]
Cao XJ, He XY, Yang Y, Zhu Q.
europepmc +1 more source
Adverse reaction of a combined treatment for unresectable liver cancer
Ren Jianjun, Jiang Tao, Peng Rui
doaj +1 more source
Cancer treatment by radioimmunotherapy: insights from a dynamical model of cancer stem cells and hypoxia effects. [PDF]
Mvogo A, Essongo FE, Hubert Ben-Bolie G.
europepmc +1 more source
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts. [PDF]
Vaughn BA +15 more
europepmc +1 more source
COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1<sup>+</sup>CD8<sup>+</sup> T cell infiltration in NSCLC. [PDF]
Ma L +5 more
europepmc +1 more source
cGAS/STING-mediated γδ T cell recruitment drives radioresistance: implications for improving radioimmunotherapy outcomes. [PDF]
Braman BC, Raleigh DR.
europepmc +1 more source
Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer. [PDF]
Yoon AR +13 more
europepmc +1 more source
Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions. [PDF]
Diao Z +5 more
europepmc +1 more source

